Filing Details
- Accession Number:
- 0001209191-23-008836
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-13 18:10:11
- Reporting Period:
- 2022-02-10
- Accepted Time:
- 2023-02-13 18:10:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1564406 | Oak Street Health Inc. | OSH | Services-Health Services (8000) | 843446686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1793313 | M Geoffrey Price | C/O Oak Street Health, Inc. 30 W. Monroe St., Suite 1200 Chicago IL 60603 | Chief Innovation Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2023-02-10 | 7,413 | $21.00 | 3,882,276 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2023-02-10 | 7,413 | $35.60 | 3,874,863 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Employee Stock Option (Right to Buy) | Disposition | 2023-02-10 | 7,413 | $21.00 | 7,413 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,141,868 | 2030-08-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.001 Par Value | 1,073,270 | Indirect | By Price-Uhl Living Trust |
Footnotes
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- The reported securities include the aggregate options, all of which were issued at the time of the Issuer's initial public offering, held by the Reporting Person, a portion of which remains subject to vesting.
Billionaire Hedge Funds
